Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04887_nanopub.RAthCjX6a65_wah7_wwgrpJwOrvCzjrteUSu2bzoHQ67M#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB04887 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04887 label "Brecanavir [drugbank:DB04887]" assertion.
- drugbank:DB04887 seeAlso DB04887 assertion.
- drugbank:DB04887 identifier "drugbank:DB04887" assertion.
- drugbank:DB04887 description "Brecanavir (VX-385) an orally active aspartic protease inhibitor (PI), under investigation by Vertex and GlaxoSmithKline for the treatment of HIV. In July 2006, Vertex indicated that it expected GSK to initiate phase III trials of the drug in 2007. In December of 2006 GSK announced a decision to discontinue the development of brecanavir for the treatment of HIV. The decision was based on issues regarding the formulation of the drug." assertion.
- drugbank:DB04887 title "Brecanavir" assertion.
- drugbank:DB04887 bio2rdf_vocabulary:identifier "DB04887" assertion.
- drugbank:DB04887 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04887 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04887" assertion.
- drugbank:DB04887 bio2rdf_vocabulary:x-identifiers.org DB04887 assertion.
- drugbank:DB04887 drugbank_vocabulary:drugbank-id "DB04887" assertion.
- drugbank:DB04887 drugbank_vocabulary:x-cas cas:313682-08-5 assertion.
- drugbank:DB04887 drugbank_vocabulary:x-chemspider chemspider:4675192 assertion.
- drugbank:DB04887 drugbank_vocabulary:x-pubchemcompound pubchem.compound:5743186 assertion.
- drugbank:DB04887 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:10318428 assertion.
- drugbank:DB04887 drugbank_vocabulary:x-kegg kegg:D03253 assertion.
- drugbank:DB04887 drugbank_vocabulary:x-bindingdb bindingdb:4685 assertion.